CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.78, no.1, pp.143-150, 2016 (Journal Indexed in SCI)
Article / Article
Title of Journal :
CANCER CHEMOTHERAPY AND PHARMACOLOGY
The aim of this study was to evaluate safety and toxicity of chronomodulated capecitabine administered in the morning and at noon according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of first-line XELOX chemotherapy in patients with metastatic colorectal cancer.